SARAH PROFFIT: Open Payments
NPI 1104459270 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,252 in 100 payments from 18 companies in 2025. Trend: 2023 $2,162 · 2024 $2,814 · 2025 $3,252
Food & beverage: $2,938Travel & lodging: $314
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 2 | $669 |
| ABBVIE INC. | 28 | $607 |
| Madrigal Pharmaceuticals | 10 | $475 |
| Janssen Biotech, Inc. | 11 | $191 |
| Regeneron Healthcare Solutions, Inc. | 7 | $189 |
| QOL Medical, LLC | 5 | $169 |
| Phathom Pharmaceuticals, Inc. | 6 | $138 |
| Lilly USA, LLC | 5 | $132 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $111 |
| GENZYME CORPORATION | 4 | $109 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, MAVYRET, Sucraid, VOQUEZNA, OMVOH, LINZESS.
Industry payments across NY — which companies pay providers there.
